Early prophylaxis of cardiomyopathy with beta-blockers and angiotensin receptor blockers in patients with Duchenne muscular dystrophy

다국어 초록 (Multilingual Abstract)

.

참고문헌 (Reference)

1 Bourke JP, "Preventing Cardiomyopathy in DMD. A randomized placebo-controlled drug trial" 11 : e661-e668, 2021

2 Duboc D, "Perindopril preventive treatment on mortality in Duchenne muscular dystrophy : 10 years' follow-up" 154 : 596-602, 2007

3 Kim HG, "Is it possible for children in duchenne muscular dystrophy to preserve cardiac function with medical assistance?" 7 : 249-, 2020

4 Lanza GA, "Impairment of cardiac autonomic function in patients with Duchenne muscular dystrophy : relationship to myocardial and respiratory function" 141 : 808-812, 2001

5 Murphy AP, "Effects of cardiac medications on ventricular function in patients with Duchenne muscular dystrophy-related cardiomyopathy" 64 : 163-171, 2021

6 Birnkrant DJ, "Diagnosis and management of Duchenne muscular dystrophy, part 2 : respiratory, cardiac, bone health, and orthopaedic management" 17 : 347-361, 2018

7 Thomas TO, "Correlation of heart rate and cardiac dysfunction in Duchenne muscular dystrophy" 33 : 1175-1179, 2012

8 McNally EM, "Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy" 131 : 1590-1598, 2015

9 Cappato R, "Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia : a prospective, randomized, placebo-controlled, double-blind, crossover evaluation" 60 : 1323-1329, 2012

10 Yotsukura M, "Circadian rhythm and variability of heart rate in Duchenne-type progressive muscular dystrophy" 76 : 947-951, 1995

11 Ruzieh M, "Challenges in treatment of inappropriate sinus tachycardia" 14 : 42-44, 2018

12 Thomas TO, "Autonomic dysfunction by heart rate variability analyses correlates with myocardial fibrosis in pediatric duchenne muscular dystrophy" 61 : E590-, 2013